Cargando…
RIOK1 is associated with non-small cell lung cancer clinical characters and contributes to cancer progression
Lung cancer is one of the most common malignant tumors and is currently the leading cause of cancer-related deaths worldwide. Although the treatment strategy has been significantly improved, the prognosis of lung cancer patients is still quite poor. RIOK1 has been reported to be highly expressed in...
Autores principales: | Wang, Rong, Chai, Wen-Shu, Pan, Dian-Zhu, Shan, Li-Na, Shi, Xuan, He, Yu-Hai, Pan, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899362/ https://www.ncbi.nlm.nih.gov/pubmed/35281872 http://dx.doi.org/10.7150/jca.64668 |
Ejemplares similares
-
First Evidence of Function for Schistosoma japonicum
riok-1 and RIOK-1
por: Mughal, Mudassar N., et al.
Publicado: (2021) -
High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
por: Liu, Kun, et al.
Publicado: (2016) -
Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers
por: Hong, Xuehui, et al.
Publicado: (2018) -
Retraction Note: High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
por: Liu, Kun, et al.
Publicado: (2023) -
Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression
por: Huang, Zhiqi, et al.
Publicado: (2020)